Business Context and Reporting Period
The Hanover Insurance Group, Inc. (NYSE: THG) filed this unaudited Form 10-Q for the three months ended March 31, 2024. Its insurance operations are reported in Core Commercial, Specialty, Personal Lines and Other. Comparisons below are with the first quarter of 2023 unless otherwise stated.
Financial Performance and Position
| Metric | Q1 2024 | Q1 2023 / comparison |
|---|---|---|
| Total revenue | $1,551.1 million | $1,443.7 million; up 7.4% |
| Net premiums written | $1,454.0 million | $1,421.5 million; up 2.3% |
| Net investment income | $89.7 million | $78.7 million; up 14.0% |
| Net realized and unrealized investment gains (losses) | $5.5 million | $(23.0) million |
| Income (loss) before tax | $145.3 million | $(17.5) million |
| Net income (loss) | $115.5 million | $(12.0) million |
| Diluted EPS | $3.18 | $(0.34) |
| Operating income before interest and taxes (non-GAAP) | $149.7 million | $13.2 million |
| Operating cash flow | $58.7 million | $18.1 million |
The improved earnings primarily reflected lower catastrophe losses, stronger current-year underwriting in Personal Lines and Specialty, and higher investment income. Total catastrophe losses were $86.9 million, down from $175.0 million. Total prior-year reserve development was favorable by $17.4 million, comprising $10.4 million of non-catastrophe development and $7.0 million of catastrophe development.
The consolidated combined ratio was 95.5%, compared with 104.4%. Core Commercial was 93.9% (104.7%); Specialty 87.6% (89.9%); Personal Lines 101.0% (112.2%). A ratio below 100% indicates underwriting profit before investment income and other items. Total losses and loss adjustment expenses were $935.2 million, versus $1,017.4 million; acquisition cost amortization was $299.0 million, versus $288.8 million; and other operating expenses were $163.1 million, versus $146.5 million.
At March 31, 2024, total assets were $14.6 billion, shareholders’ equity $2.52 billion, and debt $783.4 million. Cash and cash equivalents were $264.6 million, down from $316.1 million at year-end 2023. Cash and investments totaled $9.21 billion. Fixed maturities had a fair value of $8.02 billion against amortized cost of $8.65 billion, including $654.2 million of gross unrealized losses; management attributed these largely to interest rates and said it did not intend, nor expect to be required, to sell before recovery. Debt fair value was $734.1 million. Quarterly interest expense was $8.5 million.
Operating cash flow was positive $58.7 million; investing activities used $74.8 million and financing activities used $35.4 million. The company paid $30.5 million in common dividends, or $0.85 per share. Insurance subsidiaries’ statutory capital and surplus was $2.76 billion, up $119.6 million during the quarter. Hanover Insurance’s RBC ratio was 201% on the Industry Scale and 402% on the Regulatory Scale.
Material Changes and Segment Results
- Core Commercial: Net premiums written rose 3.0% to $582.4 million. Underwriting income was $30.9 million, compared with a $24.8 million loss, mainly reflecting lower catastrophe losses and favorable reserve development. Current-year underwriting profit excluding catastrophes was essentially flat at $42.4 million.
- Specialty: Net premiums written increased 4.8% to $339.8 million. Underwriting income rose to $38.9 million from $30.7 million, supported by lower current-year losses and catastrophe losses; favorable prior-year development was lower than a year earlier.
- Personal Lines: Net premiums written were nearly unchanged at $531.8 million. Underwriting loss narrowed to $9.1 million from $72.2 million, reflecting fewer catastrophe losses, improved current-year results and favorable reserve development. Personal auto policies in force fell 5.5% and homeowners policies in force fell 4.7% year over year.
- Available-for-sale investment losses in other comprehensive income were $34.1 million, versus a $94.3 million gain in Q1 2023, largely reflecting market-value changes. The accumulated other comprehensive loss increased to $548.9 million from $517.2 million at year-end.
Outlook, Management Commentary and Risks
The filing provides no consolidated full-year earnings or revenue guidance. Management expects Personal Lines policy counts to continue declining sequentially through 2024, as pricing actions and more selective underwriting weigh on new business and retention. In Q1, the company obtained approximately 30% homeowners and 18% personal auto pricing increases, and said it believes further pricing increases remain possible. Price competition and regulatory constraints may affect results.
Management cited renewal price increases as the primary driver of premium growth in Core Commercial and Specialty, while emphasizing disciplined underwriting and risk selection. The company expects to exit substantially all Opus investment-management operations serving unaffiliated clients by the end of Q2 2024 and transfer management of its investment-grade fixed-maturity portfolio to an external manager.
Key risks include catastrophe severity and frequency, reserve-estimate uncertainty, inflation and claims trends, regulatory limits on rate actions, policy retention and competitive conditions, reinsurance availability and collectability, and investment-market, interest-rate and credit risks. Management noted that higher rates and tighter financial conditions could increase investment defaults; adverse market or credit developments could require impairment recognition. Residual-market participation and legal or regulatory proceedings also create uncertainty. Legal matters are not expected to materially affect financial position, though an individual period’s results could be affected.
Liquidity resources include approximately $285 million of holding-company fixed maturities and cash, $137.2 million of FHLB borrowing capacity, and an unused $150 million revolving credit facility. No borrowings were outstanding under the FHLB facility or revolving credit agreement at quarter-end; the company reported compliance with debt covenants. The $1.3 billion repurchase authorization had approximately $330 million remaining; no shares were repurchased under it during the quarter. Separate share withholding for employee awards totaled 63,127 shares.
Important Facts for Investors to Verify
- Whether Personal Lines rate increases can offset declining policy counts and improve underwriting margins, particularly given its Q1 combined ratio remained above 100%.
- Whether favorable reserve development persists and whether current reserve estimates adequately reflect claims inflation, catastrophe exposure and longer-tail losses.
- Whether the $654.2 million of fixed-maturity unrealized losses recover as management expects, and how interest rates, credit spreads and defaults affect investment values and capital.
- How reinsurance recoverables, catastrophe exposure and statutory capital develop; review the full filing and prior annual report for detailed risk and reserve disclosures.
- Execution and costs of the planned Opus exit and investment-management transfer, and any implications for the Other segment.
- Dividend and capital-return capacity, including regulatory limits on subsidiary dividends and potential use of the remaining repurchase authorization.